Market revenue in 2021 | USD 22.3 million |
Market revenue in 2030 | USD 285.3 million |
Growth rate | 32.7% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.32% in 2021. Horizon Databook has segmented the India ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
India contributed to 10.9% of the Asia Pacific regional market for AI-based clinical trial solution providers in 2020. It is anticipated to be one of the fast-growing markets over the forecast period. The adoption and penetration of technological solutions are increasing in clinical research areas in the country.
This can be attributed to regulatory changes by Indian agencies to mitigate challenges posed by regulatory uncertainty. New amendments have been made to make the approval process faster and in line with global practices.
This has also led to the adoption of AI-based solutions by pharmaceutical companies, academia, and healthcare institutions for reducing the overall time of clinical research, decreasing cost, and enhancing trial results.
Horizon Databook provides a detailed overview of country-level data and insights on the India ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into India ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account